Zimbabwe has rejected a major American health deal valued at $367m (272 million pounds) spanning five years because of the United States' demand for sensitive information.
This move was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesperson later clarified that the United States was demanding access to health data for scientific study and commercial purposes but was unwilling to guarantee the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a deal suitable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Background
This development follows a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US after legal challenges were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.
Based on reports, 16 nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"In essence, our country would provide the raw materials for scientific discovery with no assurance that the end products would be available to our population if a new health crisis emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously established via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome further dialogue with our American counterparts on how future co-operation could be arranged in a manner that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that talks should continue given that much of the country's Aids initiatives depended on foreign aid.
"Where specific concerns arise, such as those involving data governance or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group said.
The situation highlights the complex tensions between receiving vital foreign assistance and safeguarding a country's data in an ever more data-driven world.